.

Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Cerilliant
US Army
Farmers Insurance
Argus Health
Cantor Fitzgerald
Cipla
UBS
Harvard Business School
Healthtrust
Mallinckrodt

Generated: September 25, 2017

DrugPatentWatch Database Preview

Suppliers and packages for NDA: 205831

« Back to Dashboard

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Rhodes Pharms
APTENSIO XR
methylphenidate hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL205831NDARhodes Pharmaceuticals L.P.42858-401-4590 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (42858-401-45)
Rhodes Pharms
APTENSIO XR
methylphenidate hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL205831NDARhodes Pharmaceuticals L.P.42858-402-4590 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (42858-402-45)
Rhodes Pharms
APTENSIO XR
methylphenidate hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL205831NDARhodes Pharmaceuticals L.P.42858-403-4590 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (42858-403-45)
Rhodes Pharms
APTENSIO XR
methylphenidate hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL205831NDARhodes Pharmaceuticals L.P.42858-404-4590 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (42858-404-45)
Rhodes Pharms
APTENSIO XR
methylphenidate hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL205831NDARhodes Pharmaceuticals L.P.42858-405-4590 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (42858-405-45)
Rhodes Pharms
APTENSIO XR
methylphenidate hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL205831NDARhodes Pharmaceuticals L.P.42858-406-4590 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (42858-406-45)
Rhodes Pharms
APTENSIO XR
methylphenidate hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL205831NDARhodes Pharmaceuticals L.P.42858-407-4590 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (42858-407-45)
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Citi
Julphar
Cantor Fitzgerald
Fish and Richardson
Daiichi Sankyo
Moodys
US Department of Justice
Chinese Patent Office
McKinsey
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot